Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2007 | 02-2007 | 11-2006 | 08-2006 | 05-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,116 | 10,114 | 58,178 | 48,824 | 31,011 |
| Depreciation Amortization | 9,736 | 4,688 | 15,228 | 10,759 | 6,796 |
| Income taxes - deferred | 139 | 608 | 5,824 | 7,137 | 4,388 |
| Accounts receivable | 3,584 | -6,996 | -21,098 | -32,072 | -30,789 |
| Accounts payable and accrued liabilities | -4,245 | 3,451 | 4,302 | 40,142 | 43,058 |
| Other Working Capital | -1,495 | -8,805 | -32,196 | -39,143 | -26,058 |
| Other Operating Activity | 4,491 | 5,205 | 24,255 | -2,429 | -8,945 |
| Operating Cash Flow | $24,326 | $8,265 | $54,493 | $33,218 | $19,461 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,775 | -3,642 | -19,170 | -15,591 | -10,985 |
| Net Acquisitions | -1,661 | -1,661 | -12,252 | -7,955 | -3,185 |
| Purchase Sale Intangibles | -4,855 | -4,790 | -4,000 | -4,000 | N/A |
| Other Investing Activity | -4,855 | -4,790 | -4,000 | -4,000 | 0 |
| Investing Cash Flow | $-14,291 | $-10,093 | $-35,422 | $-27,546 | $-14,170 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,000 | -1,000 | -7,000 | -6,000 | -2,000 |
| Common Stock Issued | 1,444 | 502 | 3,610 | 3,083 | 2,825 |
| Financing Cash Flow | $-5,556 | $-498 | $-3,390 | $-2,917 | $825 |
| Beginning Cash Position | 56,921 | 56,921 | 41,240 | 41,240 | 41,240 |
| End Cash Position | 61,400 | 54,595 | 56,921 | 43,995 | 47,356 |
| Net Cash Flow | $4,479 | $-2,326 | $15,681 | $2,755 | $6,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,326 | 8,265 | 54,493 | 33,218 | 19,461 |
| Capital Expenditure | -7,775 | -3,642 | -19,932 | -15,591 | -10,985 |
| Free Cash Flow | 16,551 | 4,623 | 34,561 | 17,627 | 8,476 |